$1.41
-0.05-3.42%
At close: Aug 28, 5:00 PM EST
$1.39
-0.02-1.42%
After Hours: Aug 28, 6:57 PM EST
Coherus Oncology Inc
CHRSNASDAQ
Coherus Oncology Earnings & Forecasts
Coherus Oncology (CHRS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Coherus Oncology Guidance
Coherus Oncology (CHRS) last issued guidance on January 13, 2025 for fiscal year 2024. The company guided revenue in the range of $255M - $260M for the period.
Compared to prior guidance, Coherus Oncology raised its revenue forecast from a prior range of $49M - $54M.
Coherus Oncology has issued 4 guidance updates between November 6, 2023 and January 13, 2025. During this period, the company raised its outlook 2 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.12 | $-0.27 | $-0.34 | $-0.32 |
| Actual | $-0.19 | $-0.25 | $-0.34 | $-0.33 |
| Surprise | -58.3% | +7.41% | 0.00% | -3.12% |
| Revenue | ||||
| Estimate | $21.6M | $14.3M | $13.7M | $12.9M |
| Actual | $14.3M | $12.3M | $12.7M | $11.6M |
| Surprise | -33.8% | -14.2% | -6.97% | -10.5% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.21 | $-0.21 | $-0.21 | $-0.21 |
| Revenue | ||||
| Consensus | $16.0M | $18.4M | — | — |
